Carl Zeiss Meditec AG (AFX.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap3.69B
Enterprise Value4.27B
P/E Ratio20.6
PEG Ratio-5.94
Price/Sales Ratio1.14
Price/Book Ratio1.41
Enterprise/Revenue1.14
Enterprise/EBITDA9.1

Fiscal Year

Fiscal YearSeptember 30, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0
Return On Equity0.06

Income Statement

Revenue2.23B
Revenue/Share30.69
Gross Profit1.18B
EBITDA346.89M
Net Income141.21M
Diluted EPS1.61

Balance Sheet

Total Cash23.9M
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share24.43

Price History

52-Week Change-19.02
52-Week High46.54
52-Week Low22.62
Moving Average 50 Days32.43
Moving Average 200 Days28.5

Statistics

Average Volume178,799
Shares Outstanding87.54M
% Held by Institutions0.01

Dividend And Splits

Trailing Annual Dividend Rate0.55
Trailing Annual Dividend Yield1.6
Payout Ratio0.41
Last Split Factor1369:1000
Last Split DateOctober 24, 2006
AD